The Medical Letter on Drugs and Therapeutics
Correction: Plenvu
Download PDF:   US English
Med Lett Drugs Ther. 2019 Jul 29;61(1577):120
 Select a term to see related articles  bowel preparation   cancer screening   Citrafleet   colonoscopy   colorectal cancer   Plenvu   Prepopik   sodium picosulfate 

In our article in issue 1564 on Plenvu for colonoscopy preparation (Med Lett Drugs Ther 2019; 61:11), the comparator drug in the DAYB trial was not Prepopik, but rather Citrafleet, a similar sodium picosulfate-based preparation that is not available in the US. Also, we said that Plenvu can be taken as a single- or split-dose regimen; we should have said that it can be taken as two doses in a single day or split over two days

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article